These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26362380)

  • 21. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
    Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
    Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
    Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
    Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
    Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
    Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial.
    Inoue Y; Liao W; Wang X; Du X; Tennigkeit F; Sasamoto H; Osakabe T; Hoshii N; Yuen N; Hong Z
    Epilepsy Res; 2021 Oct; 176():106705. PubMed ID: 34246118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
    Chung S; Sperling MR; Biton V; Krauss G; Hebert D; Rudd GD; Doty P;
    Epilepsia; 2010 Jun; 51(6):958-67. PubMed ID: 20132285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
    Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
    Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
    O'Brien TJ; Borghs S; He QJ; Schulz AL; Yates S; Biton V
    Epilepsia; 2020 Apr; 61(4):636-646. PubMed ID: 32221987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
    Villanueva V; Saiz-Diaz R; Toledo M; Piera A; Mauri JA; Rodriguez-Uranga JJ; López-González FJ; Gómez-Ibáñez A; Garcés M; González de la Aleja J; Rodríguez-Osorio X; Palao-Duarte S; Castillo A; Bonet M; Ruiz-Giménez J; Palau J; Arcediano A; Toledo M; Gago A
    Epilepsy Behav; 2016 Dec; 65():25-32. PubMed ID: 27863278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive lacosamide--5 years' clinical experience.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures.
    Farkas V; Steinborn B; Flamini JR; Zhang Y; Yuen N; Borghs S; Bozorg A; Daniels T; Martin P; Carney HC; Dimova S; Scheffer IE;
    Neurology; 2019 Sep; 93(12):e1212-e1226. PubMed ID: 31462582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
    Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
    Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lacosamide as adjunctive therapy in refractory epilepsy in adults: a systematic review.
    Paquette V; Culley C; Greanya ED; Ensom MH
    Seizure; 2015 Feb; 25():1-17. PubMed ID: 25645629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures.
    Lee JW; Alam J; Llewellyn N; Hurwitz S; Bubrick EB; Sarkis RA; Weisholtz D; Yu H; Putta S; Dworetzky BA; Pennell PB
    Clin Neuropharmacol; 2016; 39(3):128-31. PubMed ID: 26992155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
    Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.
    Farkas MK; Beller C; Bozorg A; McClung C; Roebling R; Yates T; Yuen N; Makedonska I
    Epilepsia Open; 2023 Mar; 8(1):146-153. PubMed ID: 36529709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.